Trial Outcomes & Findings for Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes (NCT NCT04310735)
NCT ID: NCT04310735
Last Updated: 2025-03-07
Results Overview
Blood-oxygen-level dependent (BOLD) signal measured using functional magnetic resonance imaging (fMRI) was analyzed as participants were presented with smoking-related and neutral cues. Following preprocessing with fMRIPrep (version 20.2.7), the FMRI Expert Analysis Tool (FEAT) from FMRIB's Software Library (FSL; version 6.0.7.4) was used to characterize brain activation differences in response to smoking-related versus neutral cues. Contrast of parameter estimate (COPE) values were calculated for each participant, and these COPE values were then extracted for two a priori regions of interest (ROIs) to compare activation patterns between the groups. Larger COPE values indicate greater differences in brain activation between smoking-related and neutral cues,
COMPLETED
NA
62 participants
Approximately Day 7 (Visit 2)
2025-03-07
Participant Flow
Participant milestones
| Measure |
Experimental: Expect-Yes
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Overall Study
STARTED
|
14
|
13
|
35
|
|
Overall Study
COMPLETED
|
13
|
9
|
27
|
|
Overall Study
NOT COMPLETED
|
1
|
4
|
8
|
Reasons for withdrawal
| Measure |
Experimental: Expect-Yes
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
3
|
8
|
|
Overall Study
Equipment malfunction
|
0
|
1
|
0
|
Baseline Characteristics
Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes
Baseline characteristics by cohort
| Measure |
Experimental: Expect-Yes
n=14 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=13 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
n=35 Participants
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
Total
n=62 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
14 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
35 Participants
n=5 Participants
|
62 Participants
n=4 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Age, Continuous
|
34.8 years
STANDARD_DEVIATION 9.6 • n=5 Participants
|
31.7 years
STANDARD_DEVIATION 9.4 • n=7 Participants
|
28.5 years
STANDARD_DEVIATION 7.3 • n=5 Participants
|
30.5 years
STANDARD_DEVIATION 8.6 • n=4 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
23 Participants
n=5 Participants
|
33 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
29 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
12 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
33 Participants
n=5 Participants
|
57 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
15 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
9 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
24 Participants
n=5 Participants
|
39 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
14 participants
n=5 Participants
|
13 participants
n=7 Participants
|
35 participants
n=5 Participants
|
62 participants
n=4 Participants
|
|
Annual Household Income
Less than $10,000
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
|
Annual Household Income
Less than $15,000 ($10,000 to less than $15,000)
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
|
Annual Household Income
Less than $20,000 ($15,000 to less than $20,000)
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Annual Household Income
Less than $25,000 ($20,000 to less than $25,000)
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
11 Participants
n=4 Participants
|
|
Annual Household Income
Less than $35,000 ($25,000 to less than $35,000)
|
4 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
17 Participants
n=4 Participants
|
|
Annual Household Income
Less than $50,000 ($35,000 to less than $50,000)
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
8 Participants
n=4 Participants
|
|
Annual Household Income
Less than $75,000 ($50,000 to less than $75,000)
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
|
Annual Household Income
$75,000 or more
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
12 Participants
n=4 Participants
|
|
Annual Household Income
Not reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
PRIMARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who completed the scan session and who provided usable brain imaging data were included in analyses. Participants in the Behavioral Testing Arm did not complete a scan session and were not assessed for brain activation during smoking-related and neutral cues.
Blood-oxygen-level dependent (BOLD) signal measured using functional magnetic resonance imaging (fMRI) was analyzed as participants were presented with smoking-related and neutral cues. Following preprocessing with fMRIPrep (version 20.2.7), the FMRI Expert Analysis Tool (FEAT) from FMRIB's Software Library (FSL; version 6.0.7.4) was used to characterize brain activation differences in response to smoking-related versus neutral cues. Contrast of parameter estimate (COPE) values were calculated for each participant, and these COPE values were then extracted for two a priori regions of interest (ROIs) to compare activation patterns between the groups. Larger COPE values indicate greater differences in brain activation between smoking-related and neutral cues,
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=11 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Brain Activation During Smoking-related and Neutral Cues
Ventromedial prefrontal cortex ROI (10-mm sphere centered at MNI x = -1, y = 46, z = -7)
|
5.8 contrast of parameter estimate
Standard Error 2.4
|
-1.6 contrast of parameter estimate
Standard Error 3.8
|
—
|
|
Brain Activation During Smoking-related and Neutral Cues
Dorsal anterior cingulate cortex ROI (10-mm sphere centered at MNI x = -2, y = 10, z = 38)
|
1.1 contrast of parameter estimate
Standard Error 3.4
|
-4.2 contrast of parameter estimate
Standard Error 2.8
|
—
|
PRIMARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who provided usable facial expression data were included in analyses.
Subjective affective responses were measured by using FaceReader software (version 9.1.7) to code the valence (positive or negative) of facial movements associated with emotional expression during the presentation of smoking-related and neutral cues. Possible values for valence range from -1 to 1, with higher values indicating greater positive affect,
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=11 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
n=9 Participants
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Coded Facial Expressions Linked to Affect During Smoking-related and Neutral Cues
Valence during neutral cues
|
-.27 units on a scale
Standard Error .10
|
-.25 units on a scale
Standard Error .09
|
-.18 units on a scale
Standard Error .08
|
|
Coded Facial Expressions Linked to Affect During Smoking-related and Neutral Cues
Valence during smoking-related cues
|
-.27 units on a scale
Standard Error .09
|
-.24 units on a scale
Standard Error .09
|
-.23 units on a scale
Standard Error .08
|
SECONDARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who provided usable ratings data were included in analyses.
Participants rated their urge to smoke during the presentation of smoking-related and neutral cues on a scale ranging from 1 (not at all) to 9 (extremely), with higher scores indicating a stronger desire to smoke. For each type of cue (smoking-related and neutral), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=11 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
n=9 Participants
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Self-reported Urge to Smoke During Smoking-related and Neutral Cues
Self-reported urge during smoking-related cues
|
7.4 units on a scale
Standard Error 0.2
|
7.1 units on a scale
Standard Error 0.6
|
6.3 units on a scale
Standard Error 0.7
|
|
Self-reported Urge to Smoke During Smoking-related and Neutral Cues
Self-reported urge during neutral cues
|
4.9 units on a scale
Standard Error 0.6
|
5.0 units on a scale
Standard Error 0.6
|
3.7 units on a scale
Standard Error 0.9
|
SECONDARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who provided usable ratings data were included in analyses.
Participants rated their current affect during the presentation of smoking-related and neutral cues on a scale ranging from 1 (very negative) to 9 (very positive), with higher scores indicating greater positive affect. For each type of cue (smoking-related and neutral), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=11 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
n=9 Participants
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Self-reported Affect During Smoking-related and Neutral Cues
Self-reported affect during smoking-related cues
|
6.1 units on a scale
Standard Error 0.3
|
5.5 units on a scale
Standard Error 0.3
|
5.1 units on a scale
Standard Error 0.7
|
|
Self-reported Affect During Smoking-related and Neutral Cues
Self-reported affect during neutral cues
|
5.9 units on a scale
Standard Error 0.2
|
5.4 units on a scale
Standard Error 0.3
|
5.9 units on a scale
Standard Error 0.3
|
SECONDARY outcome
Timeframe: Day 1 (Visit 1)Population: Only participants with usable data for the specified outcome were included in the analysis (i.e., those with missing data were excluded).
Participants' level of nicotine dependence was assessed using the total score on the Fagerström Test for Nicotine Dependence to help characterize the sample. Possible scores on the Fagerström Test for Nicotine Dependence range from 0 to 10, with higher scores indicating greater nicotine dependence.
Outcome measures
| Measure |
Experimental: Expect-Yes
n=14 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=13 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
n=17 Participants
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Nicotine Dependence
|
3.8 units on a scale
Standard Error 0.6
|
4.1 units on a scale
Standard Error 0.6
|
4.4 units on a scale
Standard Error 0.3
|
SECONDARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who completed the scan session and who provided usable brain imaging data were included in analyses (i.e., those with missing data or unusable data due to quality issue such as excessive head motion were excluded). Participants in the Behavioral Testing Arm did not complete a scan session and were not assessed for brain activation during positive and negative emotion cues.
Blood-oxygen-level dependent (BOLD) signal measured using functional magnetic resonance imaging (fMRI) was analyzed as participants were presented with cues designed to elicit positive and negative emotion. Following preprocessing with fMRIPrep (version 20.2.7), the FMRI Expert Analysis Tool (FEAT) from FMRIB's Software Library (FSL; version 6.0.7.4) was used to characterize brain activation in response to positive and negative emotion cues. Contrast of parameter estimate (COPE) values were calculated for each participant, and these COPE values were then extracted for two a priori regions of interest (ROIs) to compare activation patterns between the groups. Larger COPE values indicate greater differences in brain activation between positive and negative emotion cues.
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=12 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Brain Activation During Positive and Negative Emotion Cues
Ventromedial prefrontal cortex ROI (10-mm sphere centered at MNI x = -1, y = 46, z = -7)
|
2.4 contrast of parameter estimate
Standard Error 5.9
|
5.5 contrast of parameter estimate
Standard Error 2.8
|
—
|
|
Brain Activation During Positive and Negative Emotion Cues
Dorsal anterior cingulate cortex ROI (10-mm sphere centered at MNI x = -2, y = 10, z = 38)
|
-10.8 contrast of parameter estimate
Standard Error 4.5
|
-2.2 contrast of parameter estimate
Standard Error 5.2
|
—
|
SECONDARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who provided usable facial expression data were included in analyses.
Subjective affective responses were measured by using FaceReader software (version 9.1.7) to code the valence (positive or negative) of facial movements associated with emotional expression during the presentation of cues designed to elicit positive and negative emotion. Possible values for valence range from -1 to 1, with higher values indicating greater positive affect,
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=12 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
n=19 Participants
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Coded Facial Expressions Linked to Affect During Positive and Negative Emotion Cues
Valence during positive emotion cues
|
-.19 units on a scale
Standard Error .10
|
-.17 units on a scale
Standard Error .10
|
.03 units on a scale
Standard Error .05
|
|
Coded Facial Expressions Linked to Affect During Positive and Negative Emotion Cues
Valence during negative emotion cues
|
-.24 units on a scale
Standard Error .10
|
-.25 units on a scale
Standard Error .09
|
-.12 units on a scale
Standard Error .04
|
SECONDARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who provided usable ratings data were included in analyses. Participants in the Behavioral Testing Arm were not presented with cues designed to elicit positive and negative emotion (they were only presented with smoking-related and neutral cues) and therefore did not provide data for this secondary outcome.
Participants rated their urge to smoke during the presentation of cues designed to elicit positive and negative emotions on a scale ranging from 1 (not at all) to 9 (extremely), with higher scores indicating a stronger desire to smoke. For each type of cue (positive and negative emotion), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=12 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Self-reported Urge to Smoke During Positive and Negative Emotion Cues
Self-reported urge during positive emotion cues
|
3.0 units on a scale
Standard Error .3
|
4.0 units on a scale
Standard Error .6
|
—
|
|
Self-reported Urge to Smoke During Positive and Negative Emotion Cues
Self-reported urge during negative emotion cues
|
6.1 units on a scale
Standard Error .5
|
5.8 units on a scale
Standard Error .4
|
—
|
SECONDARY outcome
Timeframe: Approximately Day 7 (Visit 2)Population: Participants who provided usable ratings data were included in analyses.
Participants rated their current affect during the presentation of cues designed to elicit positive and negative emotion on a scale ranging from 1 (very negative) to 9 (very positive), with higher scores indicating greater positive affect. For each type of cue (positive and negative emotion), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.
Outcome measures
| Measure |
Experimental: Expect-Yes
n=9 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Experimental: Expect-No
n=12 Participants
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session.
Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
|
Behavioral Testing
n=19 Participants
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
|
|---|---|---|---|
|
Self-reported Affect During Positive and Negative Emotion Cues
Self-reported affect during negative emotion cues
|
2.8 units on a scale
Standard Error .3
|
2.9 units on a scale
Standard Error .3
|
3.7 units on a scale
Standard Error .3
|
|
Self-reported Affect During Positive and Negative Emotion Cues
Self-reported affect during positive emotion cues
|
7.6 units on a scale
Standard Error .2
|
6.7 units on a scale
Standard Error .3
|
6.4 units on a scale
Standard Error .3
|
Adverse Events
Experimental: Expect-Yes
Experimental: Expect-No
Behavioral Testing
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place